ObJEcTIVE: Although overt hypothyroidism has been documented as exerting detrimental effects on cognition and behavior, it remains controversial whether subclinical hypothyroidism or euthyroid patients with Hashimoto's thyroiditis (HT) under levothyroxine (LT4) treatment may experience any noticeable decline in cognitive function. PATIENTS: Two otherwise healthy, highly-functioning, first-degree relatives with a diagnosis of HT, under LT4 treatment for two years, were prospectively recruited into a clinical research study setting and followed for a year. MEASUrEMENTS: Thyroid functions tests and a detailed battery of tests assessing global cognitive status, attention, verbal and working memory, visuoperceptual skills, executive functions and mood were performed at baseline and at one year after recruitment. rESULTS: Overall, patients' performance on the neuropsychological battery was good and, in the majority of cognitive functions, their performance could be characterized as exceptional. No noticeable changes in any of the studied parameters were detected. cONcLUSIONS: The present case study failed to detect any noticeable changes in the cognitive and emotional function of two women with HT under LT4 treatment. The course of cognitive function of the two HT patients, evaluated by a detailed battery of tests, tends to confirm the benign nature of HT.Key words: Hashimoto's thyroiditis, Neuropsychology, LT4 treatment HORMONES 2014, 13(3):430-433 Address for correspondence: Vaitsa Giannouli, School of Medicine, Aristotle University of Thessaloniki, Greece, E-mail: giannouliv@hotmail.com Received: 30-11-2013, Accepted: 16-01-2014 Letter to the editor Chronic autoimmune (Hashimoto's) thyroiditis (HT) is the most common thyroid disorder in iodine-sufficient areas. HT is marked by the presence of complement-fixing autoantibodies to thyroid peroxidase (TPOabs) which tend to correlate with progressive thyroidal damage 1 and may lead to subclinical and overt hypothyroidism. Thyroid hormone deficiency (overt hypothyroidism) has profound and multi-systemic detrimental effects from which brain and behavior are not spared. The latter may relate to global cognitive, behavioral and emotional changes, including depression. 2 This is not the case for subclinical hypothyroidism and euthyroid HT, whether under levothyroxine (LT4) treatment or not, the effect of which on cognitive performance is somewhat controversial. Whereas it has been suggested that "a state of brain hypothyroidism in the context of systemic